Cover Image
close this bookTB/HIV: a Clinical Manual (WHO - OMS, 1996, 135 p.)
close this folderChapter 12 - Prevention of TB in HIV-infected individuals
close this folder12.3 The role of BCG in preventing TB in HIV-infected individuals
View the document12.3.1 Background
View the document12.3.2 BCG protection against TB in HIV-infected children
View the document12.3.3 BCG safety in HIV-infected children
View the document12.3.4 WHO recommended policy on BCG and HIV

12.3.4 WHO recommended policy on BCG and HIV

WHO recommended policy depends on the TB prevalence in a country, as shown on the next page. In a high TB prevalence country, the possible benefits of BCG immunisation outweigh the possible disadvantages.

COUNTRY TB PREVALENCE

WHO RECOMMENDED POLICY

high

BCG for all children (according to standard programme) except children with symptoms of HIV disease/AIDS

low

Do not give BCG immunisation to HIV-infected children